About Oncora
Oncora is a company based in Philadelphia (United States) founded in 2014 by Christopher Berlind and David Lindsay. Oncora has raised $3.11 million across 6 funding rounds from investors including University of Pennsylvania, Ben Franklin Technology Partners and Dorm Room Fund. The company has 2 employees as of December 31, 2024. Oncora operates in a competitive market with competitors including GRAIL, Color, Earli, Biovica and RainDance, among others.
- Headquarter Philadelphia, United States
- Employees 2 as on 31 Dec, 2024
- Founders Christopher Berlind, David Lindsay
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oncora Medical
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.11 M (USD)
in 6 rounds
-
Latest Funding Round
$1.89 M (USD), Seed
Sep 13, 2017
-
Investors
University of Pennsylvania
& 4 more
-
Employee Count
2
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Oncora
Unlock access to complete
Unlock access to complete
Advisor Team
1 people
Board Team
1 people
Senior Team
1 people
Chairman Team
1 people
Leadership Team
1 people
Unlock access to complete
Funding Insights of Oncora
Oncora has successfully raised a total of $3.11M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1.89 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oncora
Oncora has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Pennsylvania, Ben Franklin Technology Partners and Dorm Room Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Locked | Locked | Locked | |
|
Micro VC investments are directed toward US student-led startups.
|
Locked | Locked | Locked | |
|
Startup accelerator
|
Locked | Locked | Locked |
Investor details for Oncora
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oncora
Investment portfolio details for Oncora
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oncora
Detailed financials for Oncora
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncora Comparisons
Peer comparison for Oncora
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oncora
Oncora operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Earli, Biovica and RainDance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Early cancer detection tests are developed using synthetic biomarkers.
|
|
| Locked | Locked | Locked |
Tumor response to cancer therapies is monitored via specialized assays.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
|
| Locked | Locked | Locked |
AI software for oncology treatment planning is provided to providers.
|
Detailed competitors of Oncora
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncora
Complete news archive for Oncora
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncora
Oncora was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Oncora is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
David Lindsay is the current CEO of Oncora. They have also founded this company.
Oncora is a funded company, having raised a total of $3.11M across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Oncora is 2.
Founded in 2014 and based in Philadelphia, United States, Oncora operates in the health technology sector, focusing on oncology. Solutions such as Oncora Patient Care for data capture, Oncora Analytics for visualization and imaging, and Oncora Quality for report calculations are developed. Assistance is provided in radiation treatment processes, patient characteristic documentation, and electronic medical records management.
Oncora's top competitors include GRAIL, Earli and Valar Labs.
Oncora has 5 investors. Key investors include University of Pennsylvania, Ben Franklin Technology Partners, Dorm Room Fund, unknown, and Dreamit.